Psyence Short Long Term Debt vs Accounts Payable Analysis

PBMWW Stock   0.01  0.0003  3.41%   
Psyence Biomedical financial indicator trend analysis is much more than just breaking down Psyence Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Psyence Biomedical is a good investment. Please check the relationship between Psyence Biomedical Short Long Term Debt and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Short Long Term Debt vs Accounts Payable

Short Long Term Debt vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Psyence Biomedical Short Long Term Debt account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Psyence Biomedical's Short Long Term Debt and Accounts Payable is -0.34. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Psyence Biomedical Ltd, assuming nothing else is changed. The correlation between historical values of Psyence Biomedical's Short Long Term Debt and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Psyence Biomedical Ltd are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Short Long Term Debt i.e., Psyence Biomedical's Short Long Term Debt and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.34
Relationship DirectionNegative 
Relationship StrengthInsignificant

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Accounts Payable

An accounting item on the balance sheet that represents Psyence Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Psyence Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Psyence Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Psyence Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
Selling General Administrative is likely to climb to about 1.8 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (0.20).

Psyence Biomedical fundamental ratios Correlations

-0.7-0.720.84-0.82-0.730.990.990.77-0.59-0.760.98-0.720.981.00.840.68-0.670.60.60.60.60.60.6
-0.71.0-0.970.980.41-0.77-0.77-0.690.930.99-0.761.0-0.78-0.7-0.97-1.00.95-0.95-0.95-0.95-0.95-0.95-0.95
-0.721.0-0.980.990.45-0.79-0.79-0.680.930.99-0.781.0-0.8-0.72-0.98-0.990.95-0.95-0.95-0.95-0.95-0.95-0.95
0.84-0.97-0.98-1.0-0.550.890.890.75-0.88-0.990.88-0.980.90.841.00.96-0.930.90.90.90.90.90.9
-0.820.980.99-1.00.5-0.87-0.87-0.760.910.99-0.860.99-0.87-0.82-1.0-0.970.93-0.92-0.92-0.92-0.92-0.92-0.92
-0.730.410.45-0.550.5-0.73-0.73-0.130.340.54-0.80.45-0.79-0.73-0.55-0.360.34-0.34-0.34-0.34-0.34-0.34-0.34
0.99-0.77-0.790.89-0.87-0.731.00.77-0.69-0.820.99-0.790.990.990.890.74-0.710.70.70.70.70.70.7
0.99-0.77-0.790.89-0.87-0.731.00.77-0.69-0.820.99-0.790.990.990.890.74-0.710.70.70.70.70.70.7
0.77-0.69-0.680.75-0.76-0.130.770.77-0.58-0.650.69-0.680.70.770.750.71-0.720.60.60.60.60.60.6
-0.590.930.93-0.880.910.34-0.69-0.69-0.580.91-0.670.93-0.69-0.59-0.88-0.910.78-1.0-1.0-1.0-1.0-1.0-1.0
-0.760.990.99-0.990.990.54-0.82-0.82-0.650.91-0.820.99-0.84-0.76-0.99-0.980.93-0.93-0.93-0.93-0.93-0.93-0.93
0.98-0.76-0.780.88-0.86-0.80.990.990.69-0.67-0.82-0.781.00.980.880.73-0.70.680.680.680.680.680.68
-0.721.01.0-0.980.990.45-0.79-0.79-0.680.930.99-0.78-0.8-0.72-0.98-0.990.95-0.95-0.95-0.95-0.95-0.95-0.95
0.98-0.78-0.80.9-0.87-0.790.990.990.7-0.69-0.841.0-0.80.980.90.75-0.720.710.710.710.710.710.71
1.0-0.7-0.720.84-0.82-0.730.990.990.77-0.59-0.760.98-0.720.980.840.68-0.670.60.60.60.60.60.6
0.84-0.97-0.981.0-1.0-0.550.890.890.75-0.88-0.990.88-0.980.90.840.96-0.930.90.90.90.90.90.9
0.68-1.0-0.990.96-0.97-0.360.740.740.71-0.91-0.980.73-0.990.750.680.96-0.970.930.930.930.930.930.93
-0.670.950.95-0.930.930.34-0.71-0.71-0.720.780.93-0.70.95-0.72-0.67-0.93-0.97-0.81-0.81-0.81-0.81-0.81-0.81
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
0.6-0.95-0.950.9-0.92-0.340.70.70.6-1.0-0.930.68-0.950.710.60.90.93-0.811.01.01.01.01.0
Click cells to compare fundamentals

Psyence Biomedical Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.